AbCellera Biologics Inc.ABCLNASDAQ
Loading
Net Income Growth Recovery in ProgressRecovering
Percentile Rank71
3Y CAGR+45.3%
5Y CAGR-71.6%
Studio
Year-over-Year Change

Year-over-year net income growth rate

3Y CAGR
+45.3%/yr
Annual compound
5Y CAGR
-71.6%/yr
Recent acceleration
Percentile
P71
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive growthRecovering
PeriodValue
202510.10%
2024-11.24%
2023-192.35%
20223.29%
202129.05%
20205478.47%
2019-815.53%
20180.00%